TOX high mobility group box family member 3 rs3803662 and breast cancer risk | Zendy

Lin Li | Zendy; Guangcheng Guo | Zendy; Fang Wang | Zendy; Pengwei Lv | Zendy; Mingzhi Zhu | Zendy; Yuanting Gu | Zendy; Han Ming-li | Zendy; Xinhong Pei | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

TOX high mobility group box family member 3 rs3803662 and breast cancer risk

Author(s) -

Lin Li,

Guangcheng Guo,

Fang Wang,

Pengwei Lv,

Mingzhi Zhu,

Yuanting Gu,

Han Ming-li,

Xinhong Pei

Publication year - 2018

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.167611

Subject(s) - breast cancer , odds ratio , confidence interval , estrogen receptor , medicine , meta analysis , subgroup analysis , genetic model , oncology , gynecology , cancer , biology , genetics , gene

Some studies suggested that TOX high mobility group box family member 3 (TOX3) rs3803662 polymorphism was associated with the risk of breast cancer. However, the results were controversy. Therefore, in order to derive a more comprehensive estimation of the association between TOX3 rs3803662 polymorphism and breast cancer risk, we conducted a meta-analysis to investigate this relationship.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research